sofosbuvir has been researched along with Hepatitis A in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Y; Huang, J; Jin, Q; Ma, B; Shang, T; Tu, Z; Wang, Y; Wen, X | 1 |
| Hon, KLE; Leung, AKC; Sridhar, S; Wong, AHC | 1 |
| Jiang, W; Liu, X; Long, G; Ma, P; Muhammad, F | 1 |
1 review(s) available for sofosbuvir and Hepatitis A
| Article | Year |
|---|---|
Hepatitis E virus and Zoonosis: Recent Advances and Therapeutic Implications.
Topics: Animals; Female; Hepatitis A; Hepatitis E; Hepatitis E virus; Humans; Pregnancy; Rats; Ribavirin; Sofosbuvir; Zoonoses | 2023 |
2 other study(ies) available for sofosbuvir and Hepatitis A
| Article | Year |
|---|---|
A rare case report of iatrogenic Cushing syndrome caused by direct anti-hepatitis C virus therapy with sofosbuvir/velpatasvir.
Topics: Adrenocorticotropic Hormone; Antiviral Agents; Cushing Syndrome; Female; Genotype; Hepacivirus; Hepatitis A; Hepatitis C, Chronic; Humans; Hydrocortisone; Middle Aged; Sofosbuvir; Treatment Outcome | 2022 |
Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system.
Topics: Antiviral Agents; Drug Repositioning; Fluorescence; Genes, Reporter; Green Fluorescent Proteins; Hepatitis A; Hepatitis A virus; Hepatocytes; Humans; Inhibitory Concentration 50; Luminescent Measurements; Real-Time Polymerase Chain Reaction; Reproducibility of Results; RNA, Viral; Sofosbuvir; Virus Replication | 2018 |